Lyfegen

📍 Basel, Switzerland🗓 Founded 2018👥 42 employees💰 Last funded Dec 2024
Hospitals and Health Care🌐 lyfegen.com
Website LinkedIn
Lyfegen is an independent provider of access, pricing and rebate management software designed for the healthcare industry. Lyfegen solutions are used by health insurances, governments, hospital payers, and pharmaceutical companies around the globe to dramatically reduce the administrative burden of implementing and managing complex drug pricing agreements and to optimize rebates and get better value from those agreements. Lyfegen maintains the world’s largest digital repository of innovative drug pricing models and public agreements and offers access to a robust drug pricing simulator designed to dynamically simulate complex drug pricing scenarios to understand full financial impact. Headquartered in Basel, Switzerland, the company was founded in 2018 and has a market presence in Europe, North America, and the Middle East.
3
Total investors
0
Early stage
1
Mid stage
2
Late stage
2018
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Israel
1
Austria
1
Switzerland
1
Investor activity2022–2024 · investors recorded per year
2022120242
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Lyfegen?
Lyfegen has 3 investors on record on gritt.io, 1 mid-stage and 2 late-stage investors.
When did Lyfegen last raise funding?
The most recent investment in Lyfegen recorded on gritt.io was in December 2024.
When was Lyfegen founded?
Lyfegen was founded in 2018.
What industry is Lyfegen in?
Lyfegen operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Lyfegen based?
Lyfegen is headquartered in Basel, Switzerland.